Delivering this ambition will require collaboration across the cancer ecosystem. Keep Up With Cancer (KUWC), as the ...

The takeover – which, if completed, will be the third acquisition for UCB this decade – involves an upfront payment of $650 ...

Boston-based Kelonia is engaged in the hot area of in vivo CAR-T therapies, presenting encouraging results with its ...

Boehringer Ingelheim has announced it is expanding its global Computational Innovation footprint with a new centre dedicated ...

AstraZeneca's IL-33-targeting antibody tozorakimab has hit the target in the third of three phase 3 trials in chronic ...

Digital health companies, clinical trial technology providers, and life sciences suppliers continued to invest in senior ...

President Donald Trump has signed an executive order directing the FDA to reduce regulatory hurdles that stand in the way of ...

In this week's second major AI model launch for life sciences research, OpenAI has introduced GPT-Rosalind, designed to ...

Eli Lilly says it has the safety data it needs to shore up the recent speedy approval of its oral obesity therapy Foundayo, ...

The FDA may have approved Eli Lilly's oral weight-loss drug Foundayo in record time, but it still needs to see more safety ...

When Kailera revealed its plans for an IPO last month, there was a feeling that it could be huge – and that expectation has ...

Shrugging off an earlier phase 3 disappointment, Travere’s Filspari has become the first FDA-approved treatment for rare ...